Filing Flows › Medicinova (MNOV) › Q2 2025
Medicinova (MNOV) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 14, 2025
Medicinova (MNOV) reported revenue of $135K for the second quarter 2025 (Q2 2025).
Revenue$135K
Year over year—
Quarter over quarter—
Operating margin—
Net earnings−$3.3M
Medicinova, Q2 2025: revenue $135K, net loss $3.3M, operating cash flow −$2.3M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $135K | — | — |
| Operating profit | −$3.6M | — | — |
| Net earnings | −$3.3M | — | — |
| Operating cash flow | −$2.3M | — | — |
What changed
Revenue was $135K in Q2 2025.
Operating costs exceeded revenue by $3.6M, an operating margin of -2679.9%. The quarter ended with a net loss of $3.3M.
Operating cash flow was −$2.3M. Non-cash charges added back $5K of depreciation and amortization and $205K of share-based compensation. Working capital and other items added $765K.
Questions
What was Medicinova's revenue in the second quarter 2025?
Medicinova (MNOV) reported revenue of $135K for the second quarter 2025 (Q2 2025).
Source: Medicinova 10-Q on SEC EDGAR.